U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07778862) titled 'A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gynecological Tumors and Other Solid Tumors' on Aug. 18.
Brief Summary: This study is an open-label, multicenter, dose-escalation and expansion, non-randomized Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of SI-B036 bispecific antibody injection in patients with locally advanced or metastatic gynecological tumors and other solid tumors.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Gynecological Tumors
Solid Tumors
Intervention:
DRUG: SI-B036
Administration by intra...